Cargando…
The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis
BACKGROUD: Resection is still the only potentially curative treatment for patients with intrahepatic cholangiocarcinoma (ICC), but the prognosis remains far from satisfactory. However, the benefit of adjuvant therapy (AT) remains controversial, although it has been conducted prevalently. Hence, a me...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034847/ https://www.ncbi.nlm.nih.gov/pubmed/32084210 http://dx.doi.org/10.1371/journal.pone.0229292 |
_version_ | 1783499954784829440 |
---|---|
author | Ke, Qiao Lin, Nanping Deng, Manjun Wang, Lei Zeng, Yongyi Liu, Jingfeng |
author_facet | Ke, Qiao Lin, Nanping Deng, Manjun Wang, Lei Zeng, Yongyi Liu, Jingfeng |
author_sort | Ke, Qiao |
collection | PubMed |
description | BACKGROUD: Resection is still the only potentially curative treatment for patients with intrahepatic cholangiocarcinoma (ICC), but the prognosis remains far from satisfactory. However, the benefit of adjuvant therapy (AT) remains controversial, although it has been conducted prevalently. Hence, a meta-analysis was warranted to evaluate the effect of AT for patients with ICC after resection. PATIENTS AND METHODS: PubMed, MedLine, Embase, the Cochrane Library, Web of Science were used to identify potentially eligible studies from Jan.1(st) 1990 to Aug. 31(st) 2019, investigating the effect of AT for patients with ICC after resection. Primary endpoint was overall survival (OS), and secondary endpoints was recurrence-free survival (RFS). Hazard ratio (HR) with 95% confidence interval (CI) was used to determine the effect size. RESULTS: 22 studies with 10181 patients were enrolled in this meta-analysis, including 832 patients in the chemotherapy group, 309 patients in the transarterial chemoembolization (TACE) group, 1192 patients in the radiotherapy group, 235 patients in the chemoradiotherapy group, and 6424 patients in the non-AT group. The pooled HR for the OS rate and RFS rate in the AT group were 0.63 (95%CI 0.52~0.74), 0.74 (95%CI 0.58~0.90), compared with the non-AT group. Subgroup analysis showed that the pooled HR for the OS rate in the AT group compared with non-AT group were as follows: chemotherapy group was 0.57 (95%CI = 0.44~0.70), TACE group was 0.56 (95%CI = 0.31~0.82), radiotherapy group was 0.71 (95%CI = 0.39~1.03), chemoradiotherapy group was 0.73 (95%CI = 0.57~0.89), positive resection margin group was 0.60 (95%CI = 0.51~0.69), and lymph node metastasis (LNM) group was 0.67 (95%CI = 0.57~0.76). CONCLUSION: With the current data, we concluded that AT such as chemotherapy, TACE and chemoradiotherapy could benefit patients with ICC after resection, especially those with positive resection margin and LNM, but the conclusion needed to be furtherly confirmed. |
format | Online Article Text |
id | pubmed-7034847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-70348472020-02-27 The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis Ke, Qiao Lin, Nanping Deng, Manjun Wang, Lei Zeng, Yongyi Liu, Jingfeng PLoS One Research Article BACKGROUD: Resection is still the only potentially curative treatment for patients with intrahepatic cholangiocarcinoma (ICC), but the prognosis remains far from satisfactory. However, the benefit of adjuvant therapy (AT) remains controversial, although it has been conducted prevalently. Hence, a meta-analysis was warranted to evaluate the effect of AT for patients with ICC after resection. PATIENTS AND METHODS: PubMed, MedLine, Embase, the Cochrane Library, Web of Science were used to identify potentially eligible studies from Jan.1(st) 1990 to Aug. 31(st) 2019, investigating the effect of AT for patients with ICC after resection. Primary endpoint was overall survival (OS), and secondary endpoints was recurrence-free survival (RFS). Hazard ratio (HR) with 95% confidence interval (CI) was used to determine the effect size. RESULTS: 22 studies with 10181 patients were enrolled in this meta-analysis, including 832 patients in the chemotherapy group, 309 patients in the transarterial chemoembolization (TACE) group, 1192 patients in the radiotherapy group, 235 patients in the chemoradiotherapy group, and 6424 patients in the non-AT group. The pooled HR for the OS rate and RFS rate in the AT group were 0.63 (95%CI 0.52~0.74), 0.74 (95%CI 0.58~0.90), compared with the non-AT group. Subgroup analysis showed that the pooled HR for the OS rate in the AT group compared with non-AT group were as follows: chemotherapy group was 0.57 (95%CI = 0.44~0.70), TACE group was 0.56 (95%CI = 0.31~0.82), radiotherapy group was 0.71 (95%CI = 0.39~1.03), chemoradiotherapy group was 0.73 (95%CI = 0.57~0.89), positive resection margin group was 0.60 (95%CI = 0.51~0.69), and lymph node metastasis (LNM) group was 0.67 (95%CI = 0.57~0.76). CONCLUSION: With the current data, we concluded that AT such as chemotherapy, TACE and chemoradiotherapy could benefit patients with ICC after resection, especially those with positive resection margin and LNM, but the conclusion needed to be furtherly confirmed. Public Library of Science 2020-02-21 /pmc/articles/PMC7034847/ /pubmed/32084210 http://dx.doi.org/10.1371/journal.pone.0229292 Text en © 2020 Ke et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ke, Qiao Lin, Nanping Deng, Manjun Wang, Lei Zeng, Yongyi Liu, Jingfeng The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis |
title | The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis |
title_full | The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis |
title_fullStr | The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis |
title_full_unstemmed | The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis |
title_short | The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis |
title_sort | effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034847/ https://www.ncbi.nlm.nih.gov/pubmed/32084210 http://dx.doi.org/10.1371/journal.pone.0229292 |
work_keys_str_mv | AT keqiao theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT linnanping theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT dengmanjun theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT wanglei theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT zengyongyi theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT liujingfeng theeffectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT keqiao effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT linnanping effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT dengmanjun effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT wanglei effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT zengyongyi effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis AT liujingfeng effectofadjuvanttherapyforpatientswithintrahepaticcholangiocarcinomaaftersurgicalresectionasystematicreviewandmetaanalysis |